Analysen von Keyur Parekh
| 27.10.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.10.16 | GSK buy | Goldman Sachs Group Inc. | |
| 27.10.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 27.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 19.10.16 | GSK buy | Goldman Sachs Group Inc. | |
| 19.10.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.10.16 | Merck Neutral | Goldman Sachs Group Inc. | |
| 10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 04.10.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 22.09.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 21.09.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 21.09.16 | GSK buy | Goldman Sachs Group Inc. | |
| 20.09.16 | GSK buy | Goldman Sachs Group Inc. | |
| 15.09.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 15.09.16 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 07.09.16 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 06.09.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.09.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 25.08.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.08.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 10.08.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.07.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 28.07.16 | GSK buy | Goldman Sachs Group Inc. | |
| 28.07.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 25.07.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 19.07.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.06.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.06.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 03.06.16 | GSK buy | Goldman Sachs Group Inc. | |
| 02.06.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 31.05.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.05.16 | Bayer buy | Goldman Sachs Group Inc. | |
| 19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.05.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |